A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
Journal of Traditional Chinese Medicine
OBJECTIVE: To systematically research the postmarketing safety of Dengfeng® shenmai injection, identify potential risk factors, and ensure its clinical safety. METHODS: We investigated a comprehensive series of studies on the production process, quality standards, pharmacology, postmarketing clinical studies, and safety evaluation of Shenmai injection, including literature analysis of adverse drug reaction (ADR) case analysis and systematic review. Data from the hospital information systemdoi:10.1016/s0254-6272(14)60019-4 pmid:24660618 fatcat:etidnuds3nefngejmexsww6ex4